Analysis of the CGGA-mRNAseq_693 data set revealed that no differences in YAP1 expression among various glioma subtypes, but YAP1 was identified as the most correlated potential regulatory partner of ROCK2 with Pearson scores >0.5 (Fig. 8D, E). The gene discussed is YAP1; the disease is central nervous system cancer.